The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Nanofabrications of Erythrocyte Membrane-Coated Telmisartan Delivery System Effective for Radiosensitivity of Tumor Cells in Mice Model
Open accessAbstract
Background: Radiation stimulates the secretion of tumor stroma and induces resistance, recurrence, and metastasis of stromal-vascular tumors during radiotherapy. The proliferation and activation of tumor-associated fibroblasts (TAFs) are important reasons for the production of tumor stroma. Telmisartan (Tel) can inhibit the proliferation and activation of TAFs (resting TAFs), which may promote radiosensitization. However, Tel has a poor water solubility. Methods: In this study, self-assembled telmisartan nanoparticles (Tel NPs) were prepared by aqueous solvent diffusion method to solve the insoluble problem of Tel and achieve high drug loading of Tel. Then, erythrocyte membrane (ECM) obtained by hypotonic lysis was coated on the surface of Tel NPs (ECM/Tel) for the achievement of in vivo long circulation and tumor targeting. Immunofluorescence staining, western blot and other biological techniques were used to investigate the effect of ECM/Tel on TAFs activation inhibition (resting effect) and mechanisms involved. The multicellular spheroids (MCSs) model and mouse breast cancer cells (4T1) were constructed to investigate the effect of ECM/Tel on reducing stroma secretion, alleviating hypoxia, and the corresponding promoting radiosensitization effect in vitro. A mouse orthotopic 4T1 breast cancer model was constructed to investigate the radiosensitizing effect of ECM/Tel on inhibiting breast cancer growth and lung metastasis of breast cancer. Results: ECM/Tel showed good physiological stability and tumor-targeting ability. ECM/Tel could rest TAFs and reduce stroma secretion, alleviate hypoxia, and enhance penetration in tumor microenvironment. In addition, ECM/Tel arrested the cell cycle of 4T1 cells to the radiosensitive G2/M phase. In mouse orthotopic 4T1 breast cancer model, ECM/Tel played a superior role in radiosensitization and significantly inhibited lung metastasis of breast cancer. Conclusion: ECM/Tel showed synergistical radiosensitization effect on both the tumor microenvironment and tumor cells, which is a promising radiosensitizer in the radiotherapy of stroma-vascular tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Biomimetic strategies, including cell membrane-coated nanoparticles, were reported to enhance circulation time and immune evasion [34,44,50,56].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“Biomimetic strategies, particularly cell membrane-coated nanoparticles, were reported to enhance circulation and immune evasion [21,34,44].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Liu, Y., Liang, X., Yin, X., Lv, J., Tang, K., Ma, J., Ji, T., Zhang, H., Dong, W., Jin, X., et al. (2017) · Nature Communications · doi:10.1038/ncomms15207 · Cited by 212
RetractedIn situ click chemistry generation of cyclooxygenase-2 inhibitors
Bhardwaj, A., Kaur, J., Wuest, M., & Wuest, F. (2017) · Nature Communications · doi:10.1038/s41467-016-0009-6 · Cited by 7,448
Cancer and Radiation Therapy: Current Advances and Future Directions
Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K.-W. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.3635 · Cited by 2,880
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
ROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066 · cited 1×
“10 Under hypoxia, tumor cells usually require 2.5 to 3 times higher irradiation dose to achieve the same level of damage compared to that under normal O 2 conditions.”
BackgroundInfluentialLosartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Mechanisms of disseminated cancer cell dormancy: an awakening field
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3793 · Cited by 1,126
Research works printed but not linked: 4
- De Gasparo, 2000, Pharmacol Rev, 52, 415
- Amaya, 2004, Int J Oncol, 25, 849
- Song, 1998, J Environ Pathol Toxicol Oncol, 17, 141
- Parshad, 1984, Cancer Res, 44, 5577
Cited by
Interactions between radiotherapy resistance mechanisms and the tumor microenvironment
Li, D., Wang, J., Li, X., Wang, Z., Yu, Q., Koh, S., Wu, R., Ye, L., Guo, Y., Okoli, U. A., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104705 · Cited by 24
Xiao, H., Raza, F., Li, K., Song, J., Zafar, H., Yang, S., Su, J., & Qiu, M. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113829 · Cited by 15
Kostevšek, N. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214234 · Cited by 8
Lunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
“Biomimetic strategies, including cell membrane-coated nanoparticles, were reported to enhance circulation time and immune evasion [34,44,50,56].”
Zhang, Q., Qian, F., Cai, M., Liu, R., Chen, M., Li, Z., Chen, Y., & Lu, N. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-71 · Cited by 2
Kshirsagar, R., Bule, P., Kandula, J. S., Kundu, S., Pullapanthula, R., Sahu, B. D., & Chella, N. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107693 · Cited by 1
From Barrier to Gateway: Nanomaterials Reshaping the Tumor Microenvironment for Therapy
Xie, M., Sun, W., Hu, D., Liu, L., Han, C., Liu, W., Liu, L., Bao, X., Zhang, W., Hao, X., et al. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s573490
Metadata
- Authors
- Chen, S., Wang, C., Meng, Y., Li, P., Pan, Y., He, M., & Ni, X.
- Affiliations
- Changzhou No.2 People's Hospital (CN)
- Changzhou University (CN)
- Corresponding author
- Ni, Xinye
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2024-02
- Volume
- Volume 19
- Pages
- 1487-1508
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC10878400
- OpenAlex
- W4391849060
- Cited by
- 7
- References
- 67
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Children's Research Centre
- Jiangsu Commission of Health
- National Natural Science Foundation of China (82303692, 81871756)
- Nanjing Medical University
- Jiangsu Provincial Key Research and Development Program (BE2022720)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- telmisartan, nanoparticle drug delivery, radiosensitization, cancer-associated fibroblasts, tumor stroma, breast cancer, 4T1 cells, lung metastasis, tumor hypoxia, tumor microenvironment, G2/M cell cycle arrest, nanoparticle self-assembly
- MeSH terms
- Telmisartan, Animals, Hypoxia, Erythrocyte Membrane, Lung Neoplasms, Radiation Tolerance, Vascular Neoplasms, Cell Line, Tumor, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.